Pharmacy Loans: Financing an Independent Pharmacy Purchase, Startup or Inventory

How pharmacy loans work

A pharmacy loan is not a separate product; it is a term loan, SBA loan, line of credit or equipment loan underwritten by a lender that understands how pharmacies make money. Buying an existing pharmacy is the most common deal, and it is usually financed with an SBA 7(a) loan that covers the prescription files and goodwill, the inventory, fixtures and some working capital. Opening a new pharmacy is harder to finance because there are no prescription files yet.

Smaller needs use smaller products. A line of credit bridges the gap between buying drugs and being reimbursed; equipment financing covers automation such as dispensing robots, packaging systems and point-of-sale hardware.

Buying an existing pharmacy or opening a new one

An existing pharmacy has a payer mix, prescription counts, gross margin and cash flow on its tax returns. Those records let a lender size the loan to what the store already earns, and that is why most independent pharmacists buy rather than build. The buyer’s license, experience as a pharmacist or manager and personal credit still matter, especially for a first purchase.

A startup is underwritten on the owner and the plan: local competition, nearby prescribers, expected script volume, and how long until the store reaches break-even. Expect a larger cash contribution and closer review of the projections. Payer contracts, wholesaler accounts, state licensure and DEA registration all have to be in place before the doors open, which means months of rent and payroll before meaningful revenue.

Inventory: the largest asset in the store

In many independent pharmacies the drugs on the shelves are worth more than the fixtures and equipment combined. In an acquisition, inventory is counted at closing, usually by an outside service, and priced separately from the goodwill. The purchase agreement should say how it will be valued and which items, such as expired or short-dated stock, are excluded.

Lenders treat inventory as collateral but discount it, because drugs expire and some cannot be resold. Owners often finance inventory inside the acquisition loan, then use a line of credit for seasonal stock and new high-cost drugs. Wholesaler terms matter as well; the payment terms on your primary wholesaler account affect how much working capital you need on hand.

PBM and plan reimbursement timing

A pharmacy pays its wholesaler for a drug, dispenses it, and then waits to be paid by the plan or PBM. For Medicare Part D, federal law sets prompt-pay windows: plans must pay clean claims within 14 days when submitted electronically and 30 days otherwise. Commercial PBM contracts set their own payment cycles, so read each one.

The gap between the wholesaler’s due date and the reimbursement date is the working capital the store needs, and it grows with volume and with expensive specialty drugs. Since January 1, 2024, CMS has required Part D plans to apply all pharmacy price concessions at the point of sale, redefining the negotiated price as the lowest possible payment to the pharmacy. That makes the amount on each claim more predictable than when fees were taken back months later.

DEA registration when a pharmacy changes hands

Every pharmacy that dispenses controlled substances needs a DEA registration, applied for on DEA Form 224 and renewed every three years. If one owner operates more than one pharmacy, each location must be registered separately. When a pharmacy is sold to another registrant, the seller must notify the DEA Special Agent in Charge in writing at least 14 days before the proposed transfer, with both parties’ registration details and the transfer date.

On the day the controlled substances move, a complete inventory must be taken. Schedule II drugs are documented on DEA Form 222 or its electronic equivalent. That inventory is the seller’s final inventory and the buyer’s initial one, and the buyer keeps the transfer records for two years. Build these steps into the closing timeline, because a lender will not fund a deal that cannot legally open the next day.

SBA 7(a) terms for a pharmacy purchase

The SBA lists changes of ownership as an eligible use of 7(a) proceeds, with a $5 million maximum loan. A loan for business assets and working capital is limited to ten years under SBA rules; real estate, and equipment with a useful life over ten years, can go longer, to a maximum of 25 years including extensions. Buying the building with the pharmacy can therefore lower the blended payment.

The SBA guarantees 75 percent of loans above $150,000, which is what lets lenders finance goodwill that has no resale value on its own. On loans over $350,000, the variable rate cannot exceed the base rate plus 3 percentage points. Ask each lender how much cash it wants you to put in, whether it will accept a seller note as part of that, and what collateral it will take.

Worked example: buying an independent pharmacy

Hypothetical, not an offer. A pharmacist agrees to buy an independent pharmacy in leased space for $1,247,500, of which $412,800 is inventory counted at closing and the rest is prescription files, goodwill, fixtures and equipment. The buyer puts 10 percent down, $124,750, and finances $1,122,750 with a ten-year SBA 7(a) loan at an assumed 10.5 percent.

The payment is about $15,150 a month, or about $181,798 a year. Over ten years the buyer pays about $1,817,979, of which about $695,229 is interest. If the store’s cash flow before debt service, after paying the new owner a reasonable salary, is $243,600, it covers the loan about 1.34 times. A drop in reimbursement or a key prescriber retiring would cut that margin quickly, which is why lenders ask about payer mix and prescriber concentration.

What to have ready

For an acquisition: the letter of intent or purchase agreement, three years of the pharmacy’s tax returns and financial statements, dispensing and payer-mix reports, the lease, an inventory estimate, your pharmacist license, a personal financial statement and résumé. For a startup: a business plan with script-volume projections, the lease or letter of intent for the space, a buildout and opening-inventory budget, and proof of the cash you will contribute. Lenders will also want a timeline for state licensure, DEA registration and payer credentialing.